144 related articles for article (PubMed ID: 32869618)
1. [Violations of higher mental functions and their correction in patients undergoing video laparoscopic cholecystectomy under conditions of inhalation anesthesia with sevoflurane].
Neymark MI; Shmelev VV; Rakhmonov AA
Khirurgiia (Mosk); 2020; (8):69-74. PubMed ID: 32869618
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of cognitive dysfunction in elderly cancer patients operated on the pelvic organs in conditions of multimodal anesthesia].
Tumanyan SV; Shepelenko AV; Chekmezova SA
Khirurgiia (Mosk); 2018; (11):44-48. PubMed ID: 30531753
[TBL] [Abstract][Full Text] [Related]
3. [Correction of cognitive dysfunction after laparoscopic cholecystectomy under inhalation anesthesia with sevoflurane].
Neimark MI; Shmelev VV; Rakhmonov AA; Nazarchuk EA
Khirurgiia (Mosk); 2022; (5):52-58. PubMed ID: 35593628
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy].
Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN
Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219
[TBL] [Abstract][Full Text] [Related]
5. [Intraoperative cerebroprotection in total intravenous anesthesia in children of school age].
Ovezov AM; Panteleeva MV; Lugovoy AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):28-33. PubMed ID: 29171485
[TBL] [Abstract][Full Text] [Related]
6. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
7. [COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY].
Golub IY; Beloborodov VA; Sorokina LV; Kur'yanov AA; Borisova VM
Vestn Khir Im I I Grek; 2015; 174(4):53-5. PubMed ID: 26601519
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
[TBL] [Abstract][Full Text] [Related]
9. [Cytoflavin in total intravenous anesthesia].
Ovezov AM; Bragina SV; Prokoshev PV
Vestn Khir Im I I Grek; 2010; 169(2):64-7. PubMed ID: 20552794
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and correction of cognitive dysfunction after general anesthesia].
Novikov AY; Kovalev VA; Vinichuk NV; Chernyh YA; Golub IE; Sorokina LV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):28-31. PubMed ID: 28745667
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
Tsygan IV
Voen Med Zh; 2013 Nov; 334(11):30-5. PubMed ID: 24611306
[TBL] [Abstract][Full Text] [Related]
13. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD
Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury].
Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759
[TBL] [Abstract][Full Text] [Related]
15. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
[TBL] [Abstract][Full Text] [Related]
16. [Cytoflavin rationale for the use in treatment of patients with postsurgical hypothyroidism].
Skripkо VD; Pasko AJ; Kovalenko AL; Zaplutanov VA
Khirurgiia (Mosk); 2016; (7):53-57. PubMed ID: 27459489
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease].
Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV
Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
[No Abstract] [Full Text] [Related]
19. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A
Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
